Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2013 | 09-2012 | |
| Operating Expenses | 2,084 | 1,635 |
| Operating Income | -2,084 | -1,635 |
| Interest Expense | 244 | 63 |
| Other Income | -1,253 | -728 |
| Pre-tax Income | -3,581 | -2,426 |
| Income Tax | -389 | -323 |
| Net Income Continuous | -3,192 | -2,103 |
| Net Income | $-3,192 | $-2,103 |
| EPS Basic Total Ops | -0.05 | -0.03 |
| EPS Diluted Total Ops | -0.05 | -0.03 |
| EBITDA(a) | $-3,098 | $-2,305 |